Assignee
CHIMERIX INC
US·21 granted patents·24 pending applications·355 citations·filing 1995–2025
Top patents by PatentIndex Score
45 records- 0196US8962829B1Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2014·Granted Feb 24, 2015·35 cites·22 claims
- 0296US7749983B2Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphatesCHIMERIX INC·Filed 2007·Granted Jul 6, 2010·76 cites·16 claims
- 0395US7994143B2Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphatesCHIMERIX INC·Filed 2010·Granted Aug 9, 2011·26 cites·13 claims
- 0493US9303051B2Phosphonate ester derivatives and methods of synthesis thereofCHIMERIX INC·Filed 2015·Granted Apr 5, 2016·7 cites·9 claims
- 0593US6599887B2Methods of treating viral infections using antiviral liponucleotidesCHIMERIX INC·Filed 2001·Granted Jul 29, 2003·67 cites·11 claims
- 0691US2025109133A17-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[l,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FORTHEIR USE IN THERAPYCHIMERIX INC·Filed 2024·Application pending·0 cites
- 0790US9371344B2Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2015·Granted Jun 21, 2016·7 cites·13 claims
- 0889US9862687B2Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2016·Granted Jan 9, 2018·5 cites·18 claims
- 0989US6448392B1Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of useCHIMERIX INC·Filed 1995·Granted Sep 10, 2002·113 cites·27 claims
- 1088US10487061B2Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2018·Granted Nov 26, 2019·4 cites·31 claims
- 1188US10112909B2Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2017·Granted Oct 30, 2018·4 cites·30 claims
- 1288US2024270746A17-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2024·Application pending·0 cites
- 1386US9701706B2Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2016·Granted Jul 11, 2017·5 cites·30 claims
- 1486US9694024B2Methods of treating retroviral infections and related dosage regimesCHIMERIX INC·Filed 2016·Granted Jul 4, 2017·2 cites·20 claims
- 1586US2024216379A17-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one, salts thereof and methods of using the same in combination therapyCHIMERIX INC·Filed 2024·Application pending·0 cites
- 1685US2025084119A1Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2024·Application pending·0 cites
- 1784US9708359B2Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2016·Granted Jul 18, 2017·4 cites·22 claims
- 1879US11976068B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2021·Granted May 7, 2024·0 cites·2 claims
- 1978US11066373B2Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereofCHIMERIX INC·Filed 2019·Granted Jul 20, 2021·0 cites·17 claims
- 2073US11981700B2Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2021·Granted May 14, 2024·0 cites·13 claims
- 2171US2024199678A1MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOFCHIMERIX INC·Filed 2023·Application pending·0 cites
- 2269US10941175B2Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2019·Granted Mar 9, 2021·0 cites·16 claims
- 2369US2025382321A1MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOFCHIMERIX INC·Filed 2025·Application pending·0 cites
- 2468US2022072001A1G protein-coupled receptor (gpcr) modulation by imipridonesCHIMERIX INC·Filed 2021·Application pending·0 cites
- 2567US9956239B2Methods of treating retroviral infections and related dosage regimesCHIMERIX INC·Filed 2017·Granted May 1, 2018·0 cites·20 claims
- 2667US2018214464A1Methods of treating retroviral infections and related dosage regimesCHIMERIX INC·Filed 2018·Application pending·0 cites
- 2764US2022220146A1MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOFCHIMERIX INC·Filed 2021·Application pending·0 cites
- 2859US10407457B2Pyrrolopyrimidine nucleosides and analogs thereofCHIMERIX INC·Filed 2017·Granted Sep 10, 2019·0 cites·15 claims
- 2959US2020138835A1Formulations of brincidofovirCHIMERIX INC·Filed 2019·Application pending·0 cites
- 3058US2024207299A1Pyrrolopyrimidine nucleosides for treating or preventing a sars-cov-2 infectionCHIMERIX INC·Filed 2022·Application pending·0 cites
- 3157US11111264B2Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereofCHIMERIX INC·Filed 2018·Granted Sep 7, 2021·0 cites·16 claims
- 3256US9765100B2Nucleoside phosphonate saltsCHIMERIX INC·Filed 2015·Granted Sep 19, 2017·0 cites·18 claims
- 3353US2025241920A17-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e] pyrimidin-5 (1 h)-one, salts thereof and methods of using the same in combination therapyCHIMERIX INC·Filed 2025·Application pending·0 cites
- 3453US2015141375A1Methods of Treating Viral Associated DiseasesCHIMERIX INC·Filed 2014·Application pending·0 cites
- 3553US2011263536A1Methods of Treating Orthopox Virus Infections and Associated DiseasesCHIMERIX INC·Filed 2011·Application pending·0 cites
- 3652US2024238297A1Uses and methods for recurrent primary cns neoplasmsCHIMERIX INC·Filed 2022·Application pending·0 cites
- 3751US2014121186A1Compounds, Compositions and Methods for Treating Ocular ConditionsCHIMERIX INC·Filed 2013·Application pending·0 cites
- 3848US2014303092A1Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infectionCHIMERIX INC·Filed 2012·Application pending·0 cites
- 3947US2017333459A1Methods of treating orthopox virus infections and associated diseasesCHIMERIX INC·Filed 2017·Application pending·0 cites
- 4044US2017029451A1Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereofCHIMERIX INC·Filed 2014·Application pending·0 cites
- 4144US2017368082A1Formulations of brincidofovirCHIMERIX INC·Filed 2017·Application pending·0 cites
- 4244US2016303147A1Methods of reducing nephrotoxicity in subjects administered with nucleoside phosphonatesCHIMERIX INC·Filed 2016·Application pending·0 cites
- 4342US2015087619A1Method of mitigating virus associated end-organ damageCHIMERIX INC·Filed 2013·Application pending·0 cites
- 4442US2014011769A1Methods of Treating Retroviral Infections and Related Dosage RegimesCHIMERIX INC·Filed 2013·Application pending·0 cites
- 4536US2010297079A1Compounds, compositions and methods for treating viral infectionCHIMERIX INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHIMERIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →